GlassScriptPhysician profile
Jody Heim
NPI 1972203776
$846.18
in general payments reported to CMS, 2019-2025
18 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Psychiatric/Mental Health (Registered Nurse) provider received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $199 · 2024: $488 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $179.64 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $97.11 | 2024-2025 | Rexulti, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $79.67 | 2023-2024 | Caplyta |
| Axsome Therapeutics, INC. | $75.59 | 2024 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $69.74 | 2023 | Trintellix |
| Corium, LLC | $64.00 | 2023-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $51.27 | 2024 | Qelbree |
| Neurocrine Biosciences, INC. | $44.18 | 2023 | |
| Alkermes, INC. | $32.14 | 2024 | Aristada, Lybalvi |
| Lundbeck LLC | $23.88 | 2024 | Abilify Asimtufii |
| Indivior INC. | $20.65 | 2023 | Perseris |
| Ironshore Pharmaceuticals INC. | $19.61 | 2023 | Jornay Pm |
| Astellas Pharma US INC | $16.88 | 2024 | Veozah |
| Vanda Pharmaceuticals INC. | $16.49 | 2025 | Fanapt |
| Novo Nordisk INC | $15.56 | 2024 | Rybelsus, Ozempic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $14.61 | 2025 | Zurzuvae |
| Vertical Pharmaceuticals, LLC | $13.71 | 2025 | Relexxii |
| Phathom Pharmaceuticals, INC. | $11.45 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Heim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.